Third Annual Morris Abrams Continuing Education Seminar

An Alpha Zeta Omega Philadelphia Alumni Chapter continuing education program, presented with the Substance Use Disorder Institute at USciences.

Click here to register online NO REFUND can be made for cancellations (i.e. “no shows”) on the date of the program.

Sunday, October, 22, 2017

7 a.m. – 1 p.m. (Program One) or 7 a.m. – 3:30 p.m. (Program 2)
Note: If only attending state-approved 4 hour medical cannabis certification course, please arrive by 10:30 a.m. to sign in for course from 11 a.m. – 3:35 p.m.

Philadelphia College of Pharmacy
University of the Sciences
McNeil Science and Technology Center
45th Street at Woodland Avenue
Philadelphia, PA 19104
Directions
Parking available in large adjacent parking area at no charge.

Program Options and Registration

Choose from one of the three options:

  1. New Drug Update of 2017 and Introduction to Medical Cannabis-Just the Basics
    $125 pre-registration/$135 on-site  (5 credit hour program)
    Click here to register online
    -- OR--
  2. New Drug Update of 2017 and Medical Cannabis-Clinical Considerations & Dispensing in Pennsylvania
    $325 pre-registration/$360 on-site (7 credit hrs- includes lunch and certificate of completion for a 4 hour medical marijuana training*)
    Click here to register online.
    -- OR--
  3. Medical Cannabis-Clinical Considerations & Dispensing in Pennsylvania (4 hour certification training only)
    $325 pre-registration/ $360 on-site (4.0 CME / 0.4 CEU, includes lunch and certificate of completion for the 4 hour medical marijuana training*)
    Click here to register online.

All courses are approved for CEU through ACPE. The 4 hour Medical Cannabis course is also approved for a maximum 4.0 AMA PRA Category 1 creditsTM. Participants should only claim credit commensurate with the extent of their participation in the activity.

* This is a PA Department of Health approved 4 hour Medical Cannabis certification course, and provides 4.0 AMA PRA Category 1 creditsTM for physicians and 0.4 CEU for pharmacists. It meets the educational needs of pharmacists & medical professionals considering employment in a PA cannabis dispensary, or for physicians considering registering as a practitioner to make patient recommendations in Pennsylvania. Any healthcare professional desiring medical cannabis education may attend, and will receive a certificate of completion.

Please see the Office of Medical Marijuana for information on registration requirements and qualifications.

Program Schedule

Time Item
7 a.m. Registration, Beverage Service (coffee and tea)
7:50 a.m. New Drug Update of 2017 (0.3 ceu)
9:30 a.m. Break
9:45 a.m. New Drug Update (continued)
10:55 a.m. Q & A on New Drugs Update
11 a.m. Introduction to Medical Cannabis-Just the Basics (0.2 ceu)

Medical Cannabis-Clinical Considerations & Dispensing in Pennsylvania (0.4 ceu / 4.0 CME**)

1 p.m. End of Option 1 Break and Lunch (Options 2 and 3 only)
1:30 p.m.   Medical Cannabis continued
3:30 p.m.   Q & A on Medical Cannabis
Program ends at 3:35 p.m.

Program Description and Learning Objectives

Part One:  New Drug Update of 2017 (0.3 ceu)

ACPE No. 0226-0000-17-005-L01-P
Dr. Daniel Hussar, Remington Professor of Pharmacy, Philadelphia College of Pharmacy

Objectives

On completion of this program, the participant will:

  1. Identify the indications and routes of administration of the new drugs
  2. Identify the important pharmacokinetic properties and the unique characteristics of the new drugs
  3. Identify the most important adverse effects and precautions of the new drugs
  4. Compare the new drugs to the older therapeutic agents to which they are most similar in activity
  5. Identify information regarding the new drugs that the pharmacist should communicate to the patient

Part Two: Introduction to Medical Cannabis-Just the Basics (0.2 ceu)

ACPE No. 0226-9999-17-006-L01-P

  • Christine Roussel, PharmD, BCOP, Assistant Director of Pharmacy, Doylestown Hospital, PA
  • Joseph Morgan, MD, AACM, Senior Medical Director at Onconova Therapeutics, Newtown, PA
  • Melani Bersten, PharmD, Medical Cannabis Pharmacist, Minnesota
  • Darshan Kulkarni, Pharm D, JD, Regulatory & Compliance Attorney, Kulkarni Law Firm; Visiting Professor, Biomedical Writing & MBA Programs, University of the Sciences.

Objectives

On completion of this program, the participant will:

  1. Explain the status of cannabis as a controlled substance under federal law as well as the state to state variability in medical cannabis laws.
  2. Identify cannabinoid receptors and the non-phytocannabinoid constitutes of cannabis.
  3. Describe key features of the endocannabinoid system and cannabis pharmacology.

OR

Part Two: Medical Cannabis-Clinical Considerations & Dispensing in Pennsylvania (0.4 ceu / 4.0 CME**)

ACPE No. 0226-9999-17-007-L01-P

This is a Pennsylvania Department of Health, Office of Medical Marijuana approved 4 hour medical cannabis certification course for practitioners and medical professionals.

Faculty

  • Christine Roussel, PharmD, BCOP, Assistant Director of Pharmacy, Doylestown Hospital, PA
  • Joseph Morgan, MD, AACM, Senior Medical Director at Onconova Therapeutics, Newtown, PA
  • Melani Bersten, PharmD, Medical Cannabis Pharmacist, Minnesota
  • Darshan Kulkarni, Pharm D, JD, Regulatory & Compliance Attorney, Kulkarni Law Firm; Visiting Professor, Biomedical Writing & MBA Programs, University of the Sciences.

Educational Objectives

Upon completing this course, participants will be able to:

  • Explain the status of cannabis as a controlled substance in the U.S. under federal law as well as the state to state variability in medical cannabis laws.
  • Identify cannabinoid receptors and the non-phytocannabinoid constitutes of cannabis.
  • Describe key features of the endocannabinoid system and cannabis pharmacology.
  • Discuss best practices in patient evaluation, medical marijuana product choice and dosage, and therapeutic monitoring.
  • Explain how possible concurrent opioid use, risk management, and palliative care considerations impact patient pain management clinical care.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Society of New Jersey (MSNJ) through the joint providership of Virtua and University of the Sciences. Virtua is accredited by MSNJ to provide continuing medical education for physicians.

Credit Statement

**Virtua Health designates this continuing medical education activity for a maximum of 4.0 AMA PRA Category 1 credit(s)TMPhysicians should only claim credit commensurate with the extent of their participation in the activity. 

 

These three knowledge-based programs are acceptable for a total of 7 hours of Continuing Education credits (0.7CEU) for pharmacists in states that directly recognize ACPE providers. Credit submission to NABP will indicate hours and CEU’s based on the participants program choice and attendance.

ACPE Credits will be awarded and submitted for all pharmacist attendees who sign the attendance list, complete and return the Evaluation forms, successfully complete the post tests at the conclusion of the seminars, and submit their NABP ePID and DOB verifier (MMDD). 100% attendance is required for the chosen program.

For questions about the CE program, contact Vince Paul, RPh, Chair Alpha Zata Omega, imvincep@comcast.net or 610-662-2131.

ACPEContinuing Education

Alpha Zeta Omega, National Pharmaceutical Fraternity, Philadelphia Alumni Chapter is accredited by the Accreditation Council for Pharmacy Education as a provider of Continuing Pharmacy Education.

 

Click here to register online NO REFUND can be made for cancellations (i.e. “no shows”) on the date of the program. 

USciences Substance Use Disorders Institute  AZOVirtua

Contact:

Michele Albert, Director University Events

Address:

University of the Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495

Phone:

215-596-7619

Email:

events@usciences.edu